EchoGo® Heart Failure vs cmAngio®
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent in their application of AI to medical imaging for cardiovascular insights, but they are not direct competitors. EchoGo® Heart Failure analyzes echocardiograms to diagnose heart failure with preserved ejection fraction (HFpEF), while cmAngio® detects breast arterial calcifications (BAC) on mammograms to assess cardiovascular risk. Therefore, the choice depends on whether the clinical need is for direct cardiac disease diagnosis or cardiovascular risk assessment from mammography.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGo Heart Failure analyzes routine echocardiograms to detect Heart Failure with preserved Ejection Fraction (HFpEF), providing insights to support clinical decisions. cmAngio detects Breast Arterial Calcifications (BAC) on mammograms, offering insights into cardiovascular health and aiding early risk assessment.
EchoGo Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. For cmAngio, pricing details are not publicly available, and physicians need to contact the vendor for information on potential limited-time offers for no-cost implementation and service.
EchoGo Heart Failure analyzes routine echocardiogram video clips, specifically an apical 4-chamber view. cmAngio processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams.
EchoGo Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection, and was trained on over 10 years of outcome data. cmAngio enables BAC identification and reporting without additional radiation or procedures and offers an adjustable operating point to meet clinical goals.
EchoGo Heart Failure offers seamless integration with existing workflows and IT stacks, utilizing a DICOM workflow for report delivery to PACS. cmAngio is compatible with any DICOM-compliant viewer, boasts quick and easy installation (less than an hour), and is cybersecure and HIPAA-compliant.
EchoGo Heart Failure delivers insights from echocardiogram analysis within 20 minutes. The provided information for cmAngio does not specify a turnaround time for results, though it emphasizes quick and easy installation.
EchoGo Heart Failure is primarily designed for Cardiology, Emergency Medicine, and Internal Medicine. cmAngio is relevant for Cardiology, OB/GYN, and Radiology, focusing on women's health and cardiovascular risk assessment.